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Hepatitis C virus (HCV) infection often causes long-term persistent hepatitis, which eventually leads to
liver cirrhosis and hepatocellular carcinoma. HCV-encoded NS3/4A protease plays an important role in
HCV immune evasion by cleaving key adapter proteins VISA and TRIF of the RIG-I-like receptors and
Toll-like receptors mediated interferon (IFN) induction pathways. To further understand the roles of
NS3/4A in HCV life cycle, we identiﬁed DDB1 as a cellular substrate of NS3/4A protease by biochemical
puriﬁcation and mass spectrometry analysis. NS3/4A interacted with DDB1 and cleaved DDB1 in HCV-
infected cells. Mutagenesis indicated that NS3/4A cleaved DDB1 at the residue of C378. Overexpression
of DDB1 potentiated HCV replication, whereas knockdown of DDB1 dramatically inhibited HCV
replication. Furthermore, our data indicated that the cleavage of DDB1 by NS3/4A protease was
required for HCV replication. Our ﬁndings suggest that DDB1 is a cellular substrate of NS3/4A required
for HCV replication and provide new insight into the interaction between HCV and host cells.
& 2012 Elsevier Inc. All rights reserved.Introduction
Hepatitis C Virus (HCV) infection is a global health threat.
More than 170 million people are infected by HCV worldwide,
and many of them are subjected to chronic infection and high risk
of developing liver cirrhosis and hepatocellular carcinoma (Lauer
and Walker, 2001). HCV is a positive-strand RNA virus that
belongs to the Flaviviridae family. The HCV genome encodes a
single polyprotein of 3000 amino acids, which is processed by a
combination of host and viral proteases into at least 10 structural
and nonstructural proteins. The structural proteins include core,
E1 and E2, which are important for assembly of viral particles. The
non-structural proteins include p7, NS2, NS3, NS4A, NS4B, NS5A
and NS5B, which are important for HCV replication and interac-
tion with the host (Bartenschlager et al., 2011).
The HCV NS3/4A protease consists of two subunits, NS3 and
NS4A. NS3 contains an N-terminal serine protease domain and
a C-terminal RNA helicase domain. NS4A acts as a cofactor, which
tethers the holoenzyme complex to an intracellular membrane
compartment. Besides playing an essential role in processing viral
proteins, the NS3/4A protease also cleaves cellular proteins.
Recent studies have demonstrated that NS3/4A can cleave
VISA (also known as IPS-1, MAVS, Cardif) (Kawai et al., 2005;ll rights reserved.
uh@whu.edu.cn (H.-B. Shu).Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005) at C508 and
TRIF at C372, leading to blockade of the RIG-I-like (RLR)- and Toll-
like receptor (TLR)-mediated induction of type I interferons (IFNs)
and evasion of the innate antiviral response (Cheng et al., 2006;
Li et al., 2005a; Li et al., 2005b; Meylan et al., 2005). It has also
been reported that NS3/4A is involved in activation of EGF-
induced signaling by cleaving T-cell protein tyrosine phosphatase
(TC-PTP) (Brenndorfer et al., 2009). However, whether NS3/4A is
involved in other virus-host interactions through targeting uni-
dentiﬁed cellular substrates is largely unknown.
In this report, we identiﬁed DDB1, a core subunit of the Cul4 -
based ubiquitin ligase complex (Chen et al., 2001), as a bona ﬁde
cellular substrate of NS3/4A protease. Our ﬁndings suggest that
DDB1 is required for HCV replication and provide new insight into
the interaction between HCV and the host cells.Results
Identiﬁcation of DDB1 as an NS3/4A-associated protein
NS3/4A protease plays a vital role in HCV life cycle and virus-
cell interactions. To identify potential new cellular substrates of
NS3/4A, we performed biochemical puriﬁcation experiments.
An expression plasmid for N-terminal Flag epitope-tagged NS3/
4A was transfected into 293 cells. NS3/4A-associated proteins
were puriﬁed by anti-Flag antibody afﬁnity puriﬁcation and
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with proteins identiﬁed from control samples, we identiﬁed DDB1
as a candidate protein speciﬁcally associated with NS3/4A (Sup-
plementary Fig. 1). DDB1, a 127 kDa protein containing three
b-propeller domains (BPA–BPC) (Li et al., 2006), is a core subunit
of the Cul4 -based ubiquitin ligase complex. Conserved from yeast
to human, the Cul4-DDB1 ubiquitin ligase complex regulates diverse
cellular functions such as DNA repair (Chen et al., 2001; Kapetanaki
et al., 2006; Sugasawa et al., 2005; Wang et al., 2006), DNA
replication (Higa et al., 2003; Hu et al., 2004) and transcription
(Wertz et al., 2004), and can also be subverted by pathogenic viruses
to beneﬁt viral infection (Andrejeva et al., 2002a; Bergamaschi et al.,
2009; Casey et al., 2010; Didcock et al., 1999; Li et al., 2006; Li et al.,
2010; Schrofelbauer et al., 2007; Sharova et al., 2008).
To determine whether NS3/4A indeed interacts with DDB1, we
performed transient transfection and coimmunoprecipitation
experiments. The results indicated that NS3/4A could interact
with DDB1 (Fig. 1A). In these experiments, NS3/4A did not
interact with Cul4A and DDB2, suggesting that NS3/4A interacts
with DDB1 speciﬁcally. However, NS3/4A could impair the inter-
action between DDB1 and Cul4A (Supplementary Fig. 2). Further-
more, endogenous coimmunoprecipitation experiments indicated
that DDB1 interacted with NS3/4A in hepatic Huh-7 cells infected
with the HCV genotype 2a clone Japanese Fulminant Hepatitis 1
(JFH-1) (Fig. 1B). Interestingly, we also found that DDB1 migrated
slower in the presence of NS3/4A (Fig. 1A), and HCV infection also
caused slower migration of cellular DDB1 (Fig. 1B). The simplest
explanation for these observations is that NS3/4A may directly or
indirectly mediate post-translational modiﬁcation(s) of DDB1.DDB1 is a substrate of NS3/4A protease
NS3/4A is a serine protease which can cleave its substrates.
In our coimmunoprecipitation experiments, we found that DDB1Fig. 1. DDB1 interacts with and cleaved by NS3/4A. (A) DDB1 interacts with NS3/4A in o
Coimmunoprecipitation was performed with anti-Flag or control IgG. The immunopre
analyzed by immunoblots with anti-DDB1 or anti-HA. (B) Endogenous DDB1 interacts
infected with JFH-1 (Multiplicity of Infection, MOI: 0.3) for 3 days. Coimmunoprecipita
analyzed by immunoblot with anti-DDB1 and anti-NS3. The lysates were analyzed bywas cleaved when co-transfected with NS3/4A in 293 cells
(Fig. 1A). In Huh-7 cells, endogenous DDB1 was also cleaved after
JFH-1 infection (Fig. 1B). These results suggest that DDB1 is a
bona ﬁde cellular substrate of NS3/4A. To conﬁrm that DDB1 is
cleaved by NS3/4A protease activity, we constructed a N-terminal
and a C-terminal Flag-tagged DDB1 expression plasmid respec-
tively. We found that NS3/4A cleavage resulted in a 45 kDa
N-terminal fragment and a 82 kDa C-terminal fragment (Fig. 2A).
The added molecular size of these two fragments is consistent with
the expected size of 127 kDa of the full-length DDB1. The cleavage
of DDB1 by NS3/4A was inhibited by the NS3/4A inhibitor VX-950
(Fig. 2A). We also made recombinant DDB1 by an in vitro tran-
scription/translation method and showed that NS3/4A could cleave
recombinant DDB1 (Supplementary Fig. 3). In this experiment,
an enzymatic-inactive mutant, NS3/4A (S139A), did not cleave
DDB1 (Supplementary Fig. 3). These results conﬁrmed that DDB1 is
cleaved by NS3/4A protease.NS3/4A cleaves DDB1 at C378
It has been shown that NS3/4A cleaves at the C-terminus of a
C or T residue within a loosely deﬁned consensus sequence
(E/D)xxxx(C/T)(S/A) (where x denotes any amino acid), which
can be found at the junction of HCV non-structural proteins
(Fig. 2B) (Grakoui et al., 1993). Amino acid sequence analysis of
human DDB1 showed that 303ELLGETS309 is a potential NS3/4A
recognition sequence, with T308 serves as the potential cleavage
site. However, cleavage at T308 is predicted to generate an N-
terminal fragment of 35 kDa, which is inconsistent with the
actually cleaved N-terminal fragment of 45 kDa (Figs. 1 and 2A).
Mutation of T308 to alanine did not affect its cleavage by NS3/4A
(Supplementary Fig. 4A), also suggesting that this residue is not a
NS3/4A cleavage site.verexpression system. The 293 cells were transfected with the indicated plasmids.
cipitates were analyzed by immunoblot with anti-Flag anti-HA. The lysates were
with NS3/4A in JFH-1 infected cells. Huh-7 cells (5107) were mock-infected or
tion was performed with anti-DDB1 or control IgG. The immunoprecipitates were
immunoblots with anti-DDB1 or anti-NS3.
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found another sequence, 373GQLVTCS379 in DDB1. This was
primarily based on two previous observations: (1) signiﬁcant
alteration of cleavage efﬁciency is not found when E or D at
position P6 of the NS3/4A targeting sequence is replaced by G, F or
N (Komoda et al., 1994), and (2) NS3/4A prefers C to T at P1
position and the P6 position of the TRIF protein is P rather than E
or D (Li et al., 2005a) (Fig. 2B). A mutant of DDB1 in which C378
was changed to arginine was completely resistant to NS3/4A
cleavage (Fig. 2C), suggesting that NS3/4A cleaves DDB1 at C378.
Consistently, the cleaved N-terminal fragment of DDB1 was equal
in size with ectopically expressed DDB1(1–378) (Fig. 2D). To
conﬁrm that C378 is the cleavage site of DDB1, we further
mutated two conserved amino acids in the cleavage motif
individually, including aa379 from S to N and aa373 from G to
A. We found that both DDB1(S379N) and DDB1(G373A) were
resistant to cleavage by NS3/4A (Supplementary Fig. 4B). In
coimmunoprecipitation experiments, DDB1(C378R) could still
interact with NS3/4A (Supplementary Fig. 5), excluding the
possibility that mutation of C378 to arginine disrupts the general
structure of DDB1. Taken together, our results suggested that
DDB1 is cleaved after C378 by NS3/4A.
Since DDB1 is cleaved by NS3/4A, we wondered whether HCV
infection affects the cellular localization of DDB1. Confocal micro-
scopy with GFP-tagged DDB1 indicated that DDB1 was mostly
localized in the cytoplasmi, and this localization was not affected
by JFH-1 infection (Supplementary Fig. 6).Fig. 2. NS3/4A cleaves DDB1 at C378. (A) Cleavage of DDB1 by NS3/4A is inhibited by
C-terminal Flag-tagged DDB1 (N-Flag-DDB1 or DDB1-C-Flag respectively) and HA-NS3/
1 day before immunoblot analysis with anti-Flag or anti-HA. (B) Alignment of the jun
TC-PTP, VISA, TRIF and DDB1. (C) NS3/4A cleaves DDB1 at C378. The 293 cells we
immunoblots with anti-Flag or anti-HA. (D) DDB1 N-terminal cleavage product migrate
with the indicated plasmids, treated with VX-950 or left untreated for 1 day before imDDB1 plays a critical role in HCV replication
After identifying DDB1as a cellular substrate of NS3/4A pro-
tease, we investigated the roles of DDB1 in HCV replication.
Firstly, we overexpressed DDB1 in Huh-7 cells and then examined
its effect on replication of JFH-1 virus by RT-qPCR analysis of viral
RNA level. As shown in Fig. 3A, overexpression of DDB1 markedly
up-regulated replicated viral RNA level after JFH-1 virus infection
in a dose-dependent manner. We then determined the effect of
DDB1 deﬁciency on JFH-1 virus replication. We established two-
independent DDB1-RNAi knockdown Huh-7 cell lines by targeting
different sites of DDB1 mRNA. The expression levels of DDB1 in
these two cell lines were dramatically down-regulated in com-
parison to a control cell line (Fig. 3B). The DDB1-RNAi knockdown
cells were infected with JFH-1 virus for 3 days and then viral RNA
levels were examined by RT-qPCR . As shown in Fig. 3B, knock-
down of DDB1 dramatically inhibited viral RNA level after JFH-1
infection. In addition, immunoﬂuorescent staining experiments
with an antibody against the JFH-1 envelope E2 protein revealed
that the intracellular E2 levels in DDB1-knockdown cells were
much lower than that in control cells (Fig. 3C). We also collected
supernatants from JFH-1-infected DDB1-RNAi knockdown or
control cells and performed foci formation experiments with
naı¨ve Huh-7 .5.1 cells (Zhong et al., 2005). The results indicated
that knockdown of DDB1 dramatically reduced the level of newly
secreted viruses to 0.1% of the control sample (Fig. 3D).
Although we have used two-independent DDB1-RNAi knockdownthe NS3/4A inhibitor VX-950. The 293 cells were transfected with N-terminal or
4A. The transfected cells were treated with VX-950 (0.2 mM) or left untreated for
ction sequences of NS proteins of HCV and the potential NS3/4A cleavage sites in
re transfected with the indicated plasmids and cells lysates were analyzed by
d similarly to overexpressed DDB1(1–378) mutant. The 293 cells were transfected
munoblot analysis with with anti-Flag or anti-HA.
Fig. 3. DDB1 plays a critical role in HCV replication. (A) Overexpression of DDB1 potentiates HCV RNA replication. Huh-7 cells (1106) were transfected with the indicated
amounts of Flag-DDB1 plasmid for 24 h and then cells were split and mock-infected or infected with JFH-1 (MOI: 0.3) for 3 days. Intracellular HCV RNA levels were
determined by RT-qPCR and normalized to cellular GAPDH mRNA levels. The uninfected cell lysates were analyzed by immunoblots with anti-Flag or anti-b-actin. Graphs
show mean7SD, n¼3. (B) Knockdown of DDB1 inhibits HCV RNA replication. Control or DDB1-RNAi knockdown Huh-7 cells were mock-infected or infected with JFH-1
(MOI: 0.3) for 3 days. Intracellular HCV RNA levels were then determined by RT-qPCR and normalized to GAPDH mRNA levels. The uninfected cells lysates were also
analyzed by immunoblots with anti-DDB1 or anti-b-actin. Graphs show meanþSD, n¼3. (C) Knockdown of DDB1 inhibits HCV protein expression. Control or DDB1-RNAi
knockdown Huh-7 cells were mock-infected or infected with JFH-1 for 3 days, and the cells were then analyzed by immunoﬂuorescent staining with anti-E2 (red), and
Hoechst (blue). (D) Knockdown of DDB1 inhibits production of infectious HCV particles. Control or DDB1-RNAi knockdown Huh-7 cells were mock-infected or infected
with JFH-1 for 24 h. The cells were completely washed and fresh complete medium was added for 48 h. The JFH-1 infected medium was collected and diluted for infection
of Huh-7.5.1 cells. Three days later, cells were analyzed by immunoﬂuorescent staining with anti-E2 and HCV titers were calculated by counting positive stained cells foci.
Graphs show mean7SD, n¼3. (E) Knockdown of DDB1 inhibits RNA replication of HCV subgenomic replicon. Control or DDB1-RNAi knockdown Huh-7 cells and Huh-7
Con1 subgenomic replicon cells were cultured for 3 days. The cells (2106) were collected and intracellular HCV RNA levels were determined by RT-qPCR and normalized
to cellular GAPDH mRNA levels. Cell lysates were analyzed by immunoblots with anti-DDB1 or anti-b-actin. Graphs show mean7SD, n¼3. (F) DDB1 has no effects on HCV
entry. Control or DDB1-RNAi knockdown Huh-7 cells were infected with HCVpp for 3 days (NC: Negative Control, HCVpp pakaging without HCV E1E2). The lysates of
infected cells were assayed by luciferase reporter assays and immunoblots with anti-DDB1 or anti-b-actin. Graphs show mean7SD, n¼3. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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further conﬁrmed the conclusion by reconstitution experiments
with RNAi off-target nonsense mutants of DDB1. Rescue of DDB1
expression by these mutants in DDB1-RNAi knockdown cells
markedly restored JFH-1 RNA replication and viral particle pro-
duction (Supplementary Fig. 7). Moreover, we found that knock-
down of DDB1 dramatically suppressed the Con1 RNA level in aCon1 sub-genomic HCV replicon cells (29) (Fig. 3E). To exclude
the possibility that DDB1 affects HCV entry to host cells, we
utilized HCVpp for our analysis. HCVpp is a pseudotyped retro-
viral particle which can be produced by co-transfection of a
plasmid containing envelope-deﬁcient HIV genome pNL4-3
.Luc.R-.E- and a plasmid expressing HCV glycoproteins in 293
cells. Since HCVpp only contains the E1 and E2 envelope proteins
X. Kang et al. / Virology 435 (2013) 385–394 389of HCV, it is incapable of replicating in cells. However HCVpp can
be used to monitor whether HCV enters host cells through
quantitative luciferase reporter assays. Reporter assays performed
after HCVpp infection indicated that knockdown of DDB1 had no
signiﬁcant effect on HCV entry (Fig. 3F). Taken together, these
results suggest that DDB1 plays a critical role in HCV replication.
DDB1 cleavage is required for HCV replication
Since DDB1 is cleaved by NS3/4A and required for HCV
replication, we next investigated the effects of DDB1 cleavage
on HCV replication. We established stable Huh-7 cell lines
expressing wild-type and the C378R, S379N and G373A mutant
DDB1. These cells were mock infected or infected by JFH-1Fig. 4. DDB1 cleavage is required for HCV replication. (A) The indicated stable cell lines
RNA levels were then determined by RT-qPCR and normalized to GAPDH mRNA levels. T
anti-b-actin. Graphs show meanþSD, n¼3. (B) The indicated stable cells were mock-in
by immunoﬂuorescent staining with anti-E2 (red), and Hoechst (blue). (C) The indicate
The cells were completely washed and fresh medium was added for 48 h. The JFH-1-co
days later, cells were analyzed by immunoﬂuorescent staining with anti-E2 and HCV tit
n¼3. (D) Control or DDB1-RNAi knockdown Huh-7 cells were stably transduced wi
DDB1(C378R) respectively. Two days later, cells were mock-infected or infected with JF
RT-qPCR and normalized to GAPDH mRNA levels. The cells lysates were also analyzed
interpretation of the references to color in this ﬁgure legend, the reader is referred tovirus for 3 days, and then the intracellular viral RNA levels, E2
expression and secretion of viral particles were measured.
The results indicated that JFH-1 RNA replication and viral particle
production in the C378R, S379N and G373A mutant expressing
cells were dramatically suppressed in comparison with
control cells (Fig. 4 A–C and Supplementary Fig. 8). Since expres-
sion of endogenous DDB1 exists in these stable cell lines, we
established stable cell lines for RNAi off-target mutants of
wild-type DDB1 and DDB1(C378R) in DDB1-RNAi knockdown
cells, and performed JFH-1 infection experiments with these
cells. Again, we found that JFH-1 RNA levels were markedly
reduced in DDB1(C378R) cells (Fig. 4D). Taken together, these
results suggest that DDB1 cleavage is required for HCV
repplication.were mock-infected or infected with JFH-1 (MOI: 0.3) for 3 days. Intracellular HCV
he uninfected cells lysates were also analyzed by immunoblots with anti-DDB1 or
fected or infected with JFH-1 (MOI: 0.3) for 3 days. The cells were then analyzed
d stable cell lines were mock-infected or infected with JFH-1 (MOI: 0.3) for 24 h.
ntaining medium was collected and diluted for infection of Huh-7.5.1 cells. Three
ers were calculated by counting positive stained cells foci. Graphs show meanþSD,
th empty vector, DDB1, DDB1(C378R), off-target nonsense mutants of DDB1 or
H-1 (MOI: 0.3) for 3 days. Intracellular HCV RNA levels were then determined by
by immunoblots with anti-DDB1 or anti-actin. Graphs show meanþSD, n¼3. (For
the web version of this article.)
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Our foregoing results suggest that DDB1 cleavage is required
for HCV replication. To investigate the signiﬁcance of DDB1
cleavage products on HCV infection, we established stable cell
lines expressing DDB(1–378), DDB1(379–1140), or both frag-
ments together by retroviral-mediated gene transfer. These cellFig. 5. DDB1 cleavage products do not affect the HCV infection. (A) Huh-7 cells stably
infected with JFH-1 (MOI: 0.3) for 3 days. Intracellular HCV RNA levels were then det
lysates were analyzed by immunoblots with anti-DDB1 or anti-b-actin. Graphs sho
truncation mutants were mock-infected or infected with JFH-1 (MOI: 0.3) for 3 days. Th
Hoechst (blue). (C) Huh-7 cells stably transduced with the indicated DDB1 truncation
were completely washed and fresh complete medium was added for 48 h. The JFH-1 infe
later, cells were analyzed by immunoﬂuorescent staining with anti-E2 and HCV titers w
(D–F) Control or DDB1-RNAi-#1 (targeted sequence is within the cDNA fragment enc
vector, Flag-DDB1(1–378), Flag-DDB1(379–1140*) (*, a RNAi off-target mutant),or a com
One day post transfection, the cells were split and mock infected or infected with JFH-
viral particles (E), or viral titers in the medium (F) were then determined as described in
is referred to the web version of this article.)lines were mock infected or infected with JFH-1 virus for 3 days
and then intracellular HCV RNA, viral-particles in the cytoplasm
and culture medium were analyzed. The results indicated that
overexprssion of the cleaved fragments alone or together had no
marked effects on HCV replication (Fig. 5A–C ). To eliminate the
possibility that endogenous DDB1 may interfere the results in
these experiments, DDB1-RNAi knockdown cells were transducedtransduced with the indicated DDB1 truncation mutants were mock-infected or
ermined by RT-qPCR and normalized to GAPDH mRNA levels. The uninfected cell
w meanþSD, n¼3. (B) Huh-7 cells stably transduced with the indicated DDB1
e cells were then analyzed by immunoﬂuorescent staining with anti-E2 (red), and
mutants were mock-infected or infected with JFH-1 (MOI: 0.3) for 24 h. The cells
cted medium was collected and diluted for infection of Huh-7.5.1 cells. Three days
ere calculated by counting positive stained cells foci. Graphs show meanþSD, n¼3.
oding aa379–1140) transduced Huh-7 cells were further transfected with empty
bination of Flag-DDB1(1–378) and Flag-DDB1(379–1140*) by Lipofectamine 2000.
1(MOI: 0.3) for 3 (D, E) or 1 (F) day. Intracellular HCV RNA levels (D), intracellular
(A–C). (For interpretation of the references to color in this ﬁgure legend, the reader
X. Kang et al. / Virology 435 (2013) 385–394 391with the DDB1 truncations harboring RNAi off-target mutations,
infected with JFH-1 and then similar analyses were performed.
Again, the results indicated that overexpression of DDB1 cleavage
fragments had no marked effects on HCV replication (Fig. 5D–F ).Discussion
NS3/4A protease is not only essential for HCV polyprotein
processing, it is also a critical player in viral subverting and
evading of host immune responses (Bartenschlager et al., 1993;
Lei et al., 2009; Loo et al., 2006). Despite its key roles in HCV-host
interaction, few cellular substrates of NS3/4A have been identi-
ﬁed. Previous studies have demonstrated that TRIF and VISA are
NS3/4A substrate and cleavage of these proteins leads to suppres-
sion of the TLR- and RLR-mediated innate antiviral responses
(Li et al., 2005a; Li et al., 2005b). It has also been shown that
cleavage of TC-PTP by NS3/4A is involved in activation of the EGF-
induced signaling pathways (Brenndorfer et al., 2009). Recently,
a protein called YB-1 was reported to be a NS3/4A-interacting
protein which can affect HCV replication and viral-particle produc-
tion (Chatel-Chaix et al., 2011). In this report, we identiﬁed DDB1 as
a bona ﬁde cellular substrate of NS3/4A that is required for HCV
replication.
NS3/4A interacted with DDB1 in both mammalian overexpres-
sion system or HCV-infected cells. Site-directed mutagenesis
indicated NS3/4A cleaved DDB1 after C378. The interaction
between NS3/4A and DDB1 was not cleavage-dependent because
NS3/4A could interact with the non-cleavable DDB1(C378R)
mutant and the enzymatic-inactive NS3/4A(S139A) mutant inter-
acted with DDB1 (Supplementary Fig. 5). Overexpression of DDB1
promoted HCV replication, whereas knockdown of DDB1 inhib-
ited HCV viral RNA replication. These ﬁndings suggest that DDB1
plays an essential role in HCV replication.
Site-mutagenesis indicated that DDB1 was cleaved by NS3/4A
after C378. Several experiments suggest that the cleavage of
DDB1 is important for its role in HCV replication. Firstly, over-
expression of all the non-cleavable DDB1(C378R), DDB1(S379N)
and DDB1(G373A) mutants inhibited HCV replication; Second,
reconstitution of the RNAi-knockdown cells with wild-type but
not the non-cleavable mutant DDB1 restored HCV replication.
These results suggest that both DDB1 itself and its cleavage are
important for HCV replication. Interestingly, although the clea-
vage of DDB1 is important for HCV replication, the two cleaved
fragments, either individually or in combination, had no marked
effects on HCV replication in untransduced or DDB1-knockdown
cells. These results suggest that the cleaved fragments do not
contribute to HCV replication. The simplest explanation for these
observations is that DDB1 functions at two or more steps in HCV
replication. In an early event, HCV replication requires full-length
DDB1. After that, cleavage of DDB1 itself or de-regulation of the
Cul4-DDB1 E3 complex, but not the cleaved fragments, is required
for a later step of HCV replication. However, the mechanism
might be much more complicated and more studies are needed to
elucidate them. Currently, we are also unable to exclude the
possibility that mutations of DDB1 simply result in inactivation of
its biological functions.
Since DDB1 is a component of the Cul4-DDB1 E3 ligase
complex, we examined whether NS3/4A could be ubiquitinated
following DDB1 overexpression. The results indicated that over-
expression of DDB1 or DDB1(C378R) had no effects on NS3/4A
ubiquitination and stability (Supplementary Fig. 9), excluding
the possibility that the Cul4-DDB1 E3 ligase complex regulates
NS3/4A ubiquitination and stability.
It should be pointed out, overexpression or knockdown of
DDB1 could affect cell viability or proliferation. However, thisstarts to be observed only at 5–8 passages after its overexpression
or knockdown. Therefore, we routinely used newly prepared cells
for our experiments. We have used retrovirus-mediated gene
transfer methods for transducing Huh7 cells with DDB1 or its
RNAi plasmid. The transduced cells were selected with 4 mg/ml
puromycin for three days and the positive cells were used for the
experiments immediately. We found that the GADPH mRNA
levels in DDB1 overexpression or RNAi expressing cells had no
marked differences in comparison to control cells in real-time PCR
experiments, indicating that the cells were comparable in terms
of viability or proliferation during our experiments and the
experimental results on the roles of DDB1 in HCV replication
are reliable.
DDB1 is a multifunctional protein evolutionally conserved
from ﬁssion yeast to humans (Tang and Chu, 2002). DDB1 was
ﬁrst identiﬁed in a complex involved in UV-mediated DNA
damage response (Hwang et al., 1996). Mounting evidence has
established DDB1 as a core subunit of the Cul4A and Cul4B-based
ubiquitin ligase complex (Chen et al., 2001). In complex with
Cul4, DDB1 has been proposed to either directly dock a substrate
to the E3 machinery or indirectly recruit a substrate through a
DCAF (DDB1 Cul4 Associated Factor), which usually contains
WD40 repeats. Cul4-DDB1-DCAF forms as many as 90 E3 com-
plexes that regulate diverse cellular pathways (Angers et al.,
2006). Interestingly, it has been reported that the Cul4-DDB1
ubiquitin ligase machinery is a good hijack target for viruses. For
example, it has been shown that the V protein of SV5 and the HBx
protein of HBV can interact with DDB1 and hijack the E3
machinery for STAT1 degradation and virus replication
(Andrejeva et al., 2002a; Andrejeva et al., 2002b; Didcock et al.,
1999; Leupin et al., 2005), In addition, the HIV Vpr was also
reported to interact with DDB1 and VprBP (a kind of DCAF)
(Bergamaschi et al., 2009; Casey et al., 2010; Schrofelbauer et
al., 2007; Sharova et al., 2008). Recently, DDB1 has been reported
to be involved in infection of inﬂuenza virus, human immunode-
ﬁciency virus and cytomegalovirus (Bortz et al., 2011; Sharova
et al., 2008; Trilling et al., 2011). However, how DDB1 affects the
life cycles of these viruses is still unclear.
Structural studies indicate that DDB1 is a large multi-domain
protein featuring an independent b-propeller domain (BPB) ﬂex-
ibly connected to a clam-shaped double-propeller fold(BPA–BPC)
(Li et al., 2006). The BPA-BPC clam-shaped fold is responsible for
recruitment of distinct DCAFs (Angers et al., 2006). Interestingly,
both the V protein of SV5 and HBx interact with DDB1 at its clam-
shaped fold junction, where C378 is located on a loop of the BPC
region of this clam-shaped fold junction. It has been proposed
that interaction of the V and HBx proteins with DDB1 may change
the conformation of the BPA-BPC fold, and this may affect the
recruitment of DCAFs and promote viral replication. In this
context, it is possible that cleavage of DDB1 by NS3/4A may affect
the formation of the Cul4A-DDB1-DCAF complex, a process
required for HCV replication.
Since the Cul4A-DDB1-DCAF complex plays multiple roles in
cells, the cleavage of DDB1 by NS3/4A may affect the conforma-
tion of this complex, leading to dis-regulation of the signaling
cassettes involved. Recently, it has been shown that hepatocyte-
speciﬁc deletion of DDB1 induces liver regeneration and tumor-
igenesis (Yamaji et al., 2010). In this context, it is possible that
NS3/4A-mediated cleavage of DDB1 may contribute to hepatic
carcinogenesis induced by HCV infection. Cul4A-DDB1-DCAF
complex can regulate the histone methylation that control the
epigenetic regulation (Higa et al., 2006; Pazhouhandeh et al.,
2011), and it has been reported that virus infection may regulate
this modiﬁcation and contribute to development of carcinoma
(Fernandez and Esteller, 2010; Flower et al., 2011; Paschos and
Allday, 2010). Although many details regarding the involvement
X. Kang et al. / Virology 435 (2013) 385–394392of DDB1 in HCV replication and the signiﬁcance of its cleavage by
NS3/4A need to be further investigated, the identiﬁcation of DDB1
as a cellular substrate critical for HCV replication provides new
insights into the networks of HCV-host interaction. Furthermore,
the ﬁnding that knockdown of DDB1 dramatically inhibited HCV
replication and viral-particle production clearly justiﬁes DDB1 as
a potential target for drug development against HCV infection and
related diseases.Materials and methods
Reagents and antibodies
Mouse monoclonal antibodies against Flag, HA, and b-actin
(Sigma), HCV-NS3 (Abcam), HCV-Core(Santa Cruz Biotechnology);
rabbit monoclonal antibodies against the C-terminus of DDB1
(Epitomics), rabbit polyclonal antibodies against the N-terminus
of DDB1 (Santa Cruz Biotechnology, Proteintech Group); horse-
radish peroxidase (HRP)-conjugated goat anti-mouse IgG and
anti-rabbit IgG (Thermo); Alexa Fluor 555-conjugated anti-human
IgG, Alexa Fluor 532-conjugated anti-mouse IgG; Hoechst 33258
(Invitrogen); and the NS3/4A inhibitor VX-950 (Selleck) were
purchased from the indicated companies. Anti-E2 antibody was
provided by Dr. Dennis Burton (The Scripps Research Institute,
USA). Rabbit antiserum against HCV-NS3 was raised against NS3
recombinant protein. The Huh-7 and Huh-7 .5.1. cells were
previously described (28).Constructs
The pUC-JFH1 plasmid has been described previously (Zhong
et al., 2005). The pCMV-DDB1 plasmid was purchased from
Origene. Mammalian expression plasmids for HA- or Flag-tagged
human DDB1, Cul4A and DDB2 were constructed by standard
molecular biology techniques. DDB1 truncated mutants were
constructed in the retroviral vector pMSCV that contains a
puromycin selection marker (provided by Dr. Z. Huang, Wuhan
University). NS3/4A was ampliﬁed by PCR from the pHCV-WHU
plasmid (provided by Dr. C. Zheng, Wuhan University) and then
cloned in frame with an N-terminal Flag or HA tag. The S139A
mutant of NS3/4A, the C378R, S379N and G373A and RNAi off-
target mutants of DDB1 were generated by site-directed muta-
genesis. The pVSV-G and pGag-pol plasmids were provided by
Dr. Z. Huang (Institut Pasteur de Shanghai).
Cells and transfection
The hepatic cell lines (Huh-7 and Huh-7 .5.1.) and 293 cells
were maintained in complete Dulbecco’s modiﬁed Eagle medium
(DMEM) supplemented with 10% fetal calf serum, 10 mM HEPES,
100 mg/ml penicillin, and 100 mg/ml streptomycin. The culture of
Huh-7 Con1 subgenomic replicon needs an extra condition of
300 mg/ml G418. Transfection of 293 cells was carried out by the
calcium phosphate precipitation method. Huh7 cells were trans-
fected using lipofectamine 2000 (Invitrogen).
Protein puriﬁcation and mass spectrometry analysis
The 293 cells (1108) were transfected with an expression
plasmid for Flag-NS3/4A or empty control vector. Eighteen hours
post transfection, the transfected cells were lysed, and the lysates
were immunoprecipitated with anti-Flag conjugated agarose
beads. The anti-Flag associated proteins were eluted by Flag
peptides and the eluted proteins were digested by trypsin insolution. The tryptic peptides were analyzed by HPLC-ESI/MS/MS
using a Q-STAR Elite (Applied Biosystem) equipped with a
nanospray ionization source using conditions as previously pub-
lished (Chen et al., 2011).The tandem spectra were searched
against National Center for Biotechnology Information reference
database using the Mascot and Protein Pilot. Results were
grouped by Scaffold and compared with control and other
unrelated puriﬁcations.
Coimmunoprecipitation and immunoblot analysis
For transient transfection and coimmunoprecipitation experi-
ments, 293 cells (1107) were transfected for 24 h. The trans-
fected cells were lysed in 1 mL of lysis buffer (20 mM Tris pH 7.5,
150 mM NaCl, 1% NP-40, 1 mM EDTA, 10 mg/mL aprotinin,
10 mg/mL leupeptin, 1 mM phenylmethylsulfonyl ﬂuoride). For
each immunoprecipitation, 0.4 mL aliquot of lysate was incubated
with 0.5 mg of the indicated antibody or control IgG and 30 mL of a
1:1 slurry of Protein G Sepharose (GE Healthcare) for 4 h. The
Sepharose beads were washed three times with 1 mL of lysis
buffer containing 500 mM NaCl. The precipitates were analyzed
by standard immunoblotting procedures.
For endogenous coimmunoprecipitation experiments, Huh-7
cells (5107) were mock-infected or infected with JFH-1 for the
indicated times. The coimmunoprecipitation and immunoblot
experiments were performed as described above.
HCV infection, replication and secretion
HCV culture was described previously (Zhong et al., 2005).
HCV titers were determined with Huh-7 .5.1 cells by endpoint
dilution and immunostaining as described previously (Zhong
et al., 2005). HCV RNA levels were determined by quantitative
reverse transcription-PCR (RT-qPCR) as described previously
(Gastaminza et al., 2006). The RT-qPCR were performed on Bio-
Rad CFX. Sequences of RT-qPCR primers are as following:
GAPDH
50-GAAGGTGAAGGTCGGAGTC-30 (sense)
50-GAAGATGGTGATGGGATTTC-30 (antisense);
JFH-1
50-TCTGCGGAACCGGTGAGTA-30 (sense)
50-TCAGGCAGTACCACAAGGC-30 (antisense)
Con1
50-GCATATGACACCCGCTGTT-30(sense)
50-GTTTGACCCTTGCTGTTGA-30(antisense)
Indirect immunoﬂuorescent microscopy
Intracellular immunostaining was performed as described
previously (Zhong et al., 2005). Brieﬂy, the cells were ﬁxed with
4% paraformaldehyde and permeabilized with 0.5% Triton X-100 .
HCV E2 was stained with a human monoclonal anti-E2 antibody
(C1) and followed with an Alexa Fluor 555-conjugated secondary
antibody; HCV Core was stained with a mouse monoclonal anti-
Core antibody and followed with an Alexa Fluor 532-conjugated
secondary antibody. DNA was stained with Hoechst 33258.
HCVpp preparation and infection
HCV pseudotyped retroviral particles (HCVpp) were generated
as previously described (Hsu et al., 2003). Brieﬂy, 293 cells were
co-transfected with the envelope-deﬁcient HIV genome pNL4-3
.Luc.R-.E- and a plasmid expressing HCV glycoproteins. The
medium was replaced with complete medium after 18 h. Super-
natants were collected after 72 h and clariﬁed by centrifugation
and ﬁltration. For infection experiments, HCVpp supernatants
X. Kang et al. / Virology 435 (2013) 385–394 393were used to infect Huh-7 .5.1 cells (1104) for 72 h. The infected
cells were lysed with 20 ml of cell lysis reagent (Promega) and
measured by luciferase reporter assays.
RNAi
Double-strand oligonucleotides corresponding to the target
sequences were cloned into the pSuper.Retro RNAi plasmid
(Oligoengine Inc.). The following sequences were targeted for
human DDB1 cDNA: DDB1-RNAi #1, GTGACTTGATTGAGAGTTT;
#2, GGATGAGTGCTGTGGAAAT.
Establishment of stable cell lines
The 293 cells were co-transfected with pSuper.Retro or
pMSCV, pGag-pol and pVSV-G at a ratio of 3:3:1. The medium
was replaced with complete medium after 18 h. Supernatants
were collected after 72 h and clariﬁed by centrifugation and
ﬁltration. Huh-7 cells were infected by the pseudotyped retroviral
particles and selected by 4 mg/ml puromycin for 3 days.Acknowledgment
We thank Drs. Dennis Burton, Congyi Zheng, Zan Huang and
Zhong Huang for reagents. This work was supported by grants
from the National Natural Science Foundation of China
(30921001), and the Ministry of Science and Technology of China
(2012CB910200, 2012ZX10002007).Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.virol.2012.10.025.References
Andrejeva, J., Poole, E., Young, D.F., Goodbourn, S., Randall, R.E., 2002a. The p127
subunit (DDB1) of the UV-DNA damage repair binding protein is essential for
the targeted degradation of STAT1 by the V protein of the paramyxovirus
simian virus 5. J. Virol 76 (22), 11379–11386.
Andrejeva, J., Young, D.F., Goodbourn, S., Randall, R.E., 2002b. Degradation of
STAT1 and STAT2 by the V proteins of simian virus 5 and human parainﬂuenza
virus type 2, respectively: consequences for virus replication in the presence of
alpha/beta and gamma interferons. J. Virol. 76 (5), 2159–2167.
Angers, S., Li, T., Yi, X., MacCoss, M.J., Moon, R.T., Zheng, N., 2006. Molecular
architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery.
Nature 443 (7111), 590–593.
Bartenschlager, R., Ahlborn-Laake, L., Mous, J., Jacobsen, H., 1993. Nonstructural
protein 3 of the hepatitis C virus encodes a serine-type proteinase required for
cleavage at the NS3/4 and NS4/5 junctions. J. Virol 67 (7), 3835–3844.
Bartenschlager, R., Penin, F., Lohmann, V., Andre, P., 2011. Assembly of infectious
hepatitis C virus particles. Trends Microbiol 19 (2), 95–103.
Bergamaschi, A., Ayinde, D., David, A., Le Rouzic, E., Morel, M., Collin, G., Descamps,
D., Damond, F., Brun-Vezinet, F., Nisole, S., Margottin-Goguet, F., Pancino, G.,
Transy, C., 2009. The human immunodeﬁciency virus type 2 Vpx protein
usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block
in macrophage infection. J. Virol 83 (10), 4854–4860.
Bortz, E., Westera, L., Maamary, J., Steel, J., Albrecht, R.A., Manicassamy, B., Chase,
G., Martinez-Sobrido, L., Schwemmle, M., Garcia-Sastre, A., 2011. Host- and
strain-speciﬁc regulation of inﬂuenza virus polymerase activity by interacting
cellular proteins. MBio 2, 4.
Brenndorfer, E.D., Karthe, J., Frelin, L., Cebula, P., Erhardt, A., Schulte am Esch, J.,
Hengel, H., Bartenschlager, R., Sallberg, M., Haussinger, D., Bode, J.G., 2009.
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth
factor-induced signal transduction by cleavage of the T-cell protein tyrosine
phosphatase. Hepatology 49 (6), 1810–1820.
Casey, L., Wen, X., De Noronha, C.M., 2010. The functions of the HIV1 protein Vpr and
its action through the DCAF1.DDB1.Cullin4 ubiquitin ligase. Cytokine 51), 1–9 .
Chatel-Chaix, L., Melancon, P., Racine, M.E., Baril, M., Lamarre, D., 2011. Y-Box-
Binding protein-1 interacts with hepatitis C virus NS3/4A and inﬂuences theequilibrium between viral RNA replication and infectious particle production.
J. Virol. 85 (21), 11022–11037.
Chen, X., Wu, D., Zhao, Y., Wong, B.H., Guo, L., 2011. Increasing phosphoproteome
coverage and identiﬁcation of phosphorylation motifs through combination of
different HPLC fractionation methods. J. Chromatogr. B. Analyt. Technol.
Biomed. Life Sci. 879 (1), 25–34.
Chen, X., Zhang, Y., Douglas, L., Zhou, P., 2001. UV-damaged DNA-binding proteins
are targets of CUL-4A-mediated ubiquitination and degradation. J. Biol. Chem.
276 (51), 48175–48182.
Cheng, G., Zhong, J., Chisari, F.V., 2006. Inhibition of dsRNA-induced signaling in
hepatitis C virus-infected cells by NS3 protease-dependent and -independent
mechanisms. Proc. Natl. Acad Sci. U. S. A. 103 (22), 8499–8504.
Didcock, L., Young, D.F., Goodbourn, S., Randall, R.E., 1999. The V protein of simian
virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-
mediated degradation. J. Virol 73 (12), 9928–9933.
Fernandez, A.F., Esteller, M., 2010. Viral epigenomes in human tumorigenesis.
Oncogene 29(10), 1405–1420 .
Flower, K., Thomas, D., Heather, J., Ramasubramanyan, S., Jones, S., Sinclair, A.J.,
2011. Epigenetic control of viral life-cycle by a DNA-methylation dependent
transcription factor. PLoS One 6(10), e25922.
Gastaminza, P., Kapadia, S.B., Chisari, F.V., 2006. Differential biophysical properties
of infectious intracellular and secreted hepatitis C virus particles. J. Virol 80
(22), 11074–11081.
Grakoui, A., McCourt, D.W., Wychowski, C., Feinstone, S.M., Rice, C.M., 1993.
Characterization of the hepatitis C virus-encoded serine proteinase: determi-
nation of proteinase-dependent polyprotein cleavage sites. J. Virol. 67 (5),
2832–2843.
Higa, L.A., Mihaylov, I.S., Banks, D.P., Zheng, J., Zhang, H., 2003. Radiation-mediated
proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new
checkpoint. Nat. Cell. Biol. 5 (11), 1008–1015.
Higa, L.A., Wu, M., Ye, T., Kobayashi, R., Sun, H., Zhang, H., 2006. CUL4-DDB1
ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates
histone methylation. Nat. Cell. Biol. 8 (11), 1277–1283.
Hsu, M., Zhang, J., Flint, M., Logvinoff, C., Cheng-Mayer, C., Rice, C.M., McKeating,
J.A., 2003. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of
pseudotyped retroviral particles. Proc. Natl. Acad. Sci. U. S. A. 100 (12),
7271–7276.
Hu, J., McCall, C.M., Ohta, T., Xiong, Y., 2004. Targeted ubiquitination of CDT1 by
the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nat. Cell. Biol. 6
(10), 1003–1009.
Hwang, B.J., Liao, J.C., Chu, G., 1996. Isolation of a cDNA encoding a UV-damaged
DNA binding factor defective in xeroderma pigmentosum group E cells. Mutat.
Res. 362 (1), 105–117.
Kapetanaki, M.G., Guerrero-Santoro, J., Bisi, D.C., Hsieh, C.L., Rapic-Otrin, V., Levine,
A.S., 2006. The DDB1-CUL4ADDB2 ubiquitin ligase is deﬁcient in xeroderma
pigmentosum group E and targets histone H2A at UV-damaged DNA sites.
Proc. Natl. Acad. Sci. U. S. A. 103 (8), 2588–2593.
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J., Takeuchi,
O., Akira, S., 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type
I interferon induction. Nat. Immunol 6 (10), 981–988.
Komoda, Y., Hijikata, M., Sato, S., Asabe, S., Kimura, K., Shimotohno, K., 1994.
Substrate requirements of hepatitis C virus serine proteinase for intermole-
cular polypeptide cleavage in Escherichia coli. J. Virol. 68 (11), 7351–7357.
Lauer, G.M., Walker, B.D., 2001. Hepatitis C virus infection. N. Engl. J. Med. 345 (1),
41–52.
Lei, Y., Moore, C.B., Liesman, R.M., O’Connor, B.P., Bergstralh, D.T., Chen, Z.J., Pickles,
R.J., Ting, J.P., 2009. MAVS-mediated apoptosis and its inhibition by viral
proteins. PLoS ONE 4 (5), e5466.
Leupin, O., Bontron, S., Schaeffer, C., Strubin, M., 2005. Hepatitis B virus X protein
stimulates viral genome replication via a DDB1-dependent pathway distinct
from that leading to cell death. J. Virol. 79 (7), 4238–4245.
Li, K., Foy, E., Ferreon, J.C., Nakamura, M., Ferreon, A.C., Ikeda, M., Ray, S.C., Gale Jr.,
M., Lemon, S.M., 2005a. Immune evasion by hepatitis C virus NS3/4A protease-
mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl.
Acad. Sci. U. S. A. 102 (8), 2992–2997.
Li, T., Chen, X., Garbutt, K.C., Zhou, P., Zheng, N., 2006. Structure of DDB1 in
complex with a paramyxovirus V protein: viral hijack of a propeller cluster in
ubiquitin ligase. Cell 124 (1), 105–117.
Li, T., Robert, E.I., Van Breugel, P.C., Strubin, M., Zheng, N., 2010. A promiscuous
alpha-helical motif anchors viral hijackers and substrate receptors
to the CUL4-DDB1 ubiquitin ligase machinery. Nat. Struct. Mol. Biol. 17 (1),
105–111.
Li, X.D., Sun, L., Seth, R.B., Pineda, G., Chen, Z.J., 2005b. Hepatitis C virus protease
NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria
to evade innate immunity. Proc. Natl. Acad. Sci. U. S. A. 102 (49),
17717–17722.
Loo, Y.M., Owen, D.M., Li, K., Erickson, A.K., Johnson, C.L., Fish, P.M., Carney, D.S.,
Wang, T., Ishida, H., Yoneyama, M., Fujita, T., Saito, T., Lee, W.M., Hagedorn,
C.H., Lau, D.T., Weinman, S.A., Lemon, S.M., Gale Jr., M., 2006. Viral and
therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus
infection. Proc. Natl. Acad. Sci. U. S. A. 103 (15), 6001–6006.
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R.,
Tschopp, J., 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway
and is targeted by hepatitis C virus. Nature 437 (7062), 1167–1172.
Paschos, K., Allday, M.J., 2010. Epigenetic reprogramming of host genes in viral and
microbial pathogenesis. Trends Microbiol 18(10), 439–447 .
X. Kang et al. / Virology 435 (2013) 385–394394Pazhouhandeh, M., Molinier, J., Berr, A., Genschik, P., 2011. MSI4/FVE interacts
with CUL4-DDB1 and a PRC2-like complex to control epigenetic regulation of
ﬂowering time in Arabidopsis. Proc. Natl. Acad. Sci. U.S.A. 108 (8), 3430–3435.
Schrofelbauer, B., Hakata, Y., Landau, N.R., 2007. HIV-1 Vpr function is mediated by
interaction with the damage-speciﬁc DNA-binding protein DDB1. Proc. Natl.
Acad. Sci. U. S. A. 104 (10), 4130–4135.
Seth, R.B., Sun, L., Ea, C.K., Chen, Z.J., 2005. Identiﬁcation and characterization of
MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB
and IRF 3. Cell 122 (5), 669–682.
Sharova, N., Wu, Y., Zhu, X., Stranska, R., Kaushik, R., Sharkey, M., Stevenson, M.,
2008. Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage
restriction. PLoS Pathog. 4 (5), e1000057.
Sugasawa, K., Okuda, Y., Saijo, M., Nishi, R., Matsuda, N., Chu, G., Mori, T., Iwai, S.,
Tanaka, K., Hanaoka, F., 2005. UV-induced ubiquitylation of XPC protein
mediated by UV-DDB-ubiquitin ligase complex. Cell 121 (3), 387–400.
Tang, J., Chu, G., 2002. Xeroderma pigmentosum complementation group E and
UV-damaged DNA-binding protein. DNA Repair (Amst) 1 (8), 601–616.
Trilling, M., Le, V.T., Fiedler, M., Zimmermann, A., Bleifuss, E., Hengel, H., 2011.
Identiﬁcation of DNA-damage DNA-binding protein 1 as a conditionalessential factor for cytomegalovirus replication in interferon-gamma-
stimulated cells. PLoS Pathog 7 (6), e1002069.
Wang, H., Zhai, L., Xu, J., Joo, H.Y., Jackson, S., Erdjument-Bromage, H., Tempst, P.,
Xiong, Y., Zhang, Y., 2006. Histone H3 and H4 ubiquitylation by the CUL4-DDB-
ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol. Cell.
22 (3), 383–394.
Wertz, I.E., O’Rourke, K.M., Zhang, Z., Dornan, D., Arnott, D., Deshaies, R.J., Dixit,
V.M., 2004. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A
ubiquitin ligase. Science 303 (5662), 1371–1374.
Xu, L.G., Wang, Y.Y., Han, K.J., Li, L.Y., Zhai, Z., Shu, H.B., 2005. VISA is an adapter
protein required for virus-triggered IFN-beta signaling. Mol. Cell. 19 (6),
727–740.
Yamaji, S., Zhang, M., Zhang, J., Endo, Y., Bibikova, E., Goff, S.P., Cang, Y., 2010.
Hepatocyte-speciﬁc deletion of DDB1 induces liver regeneration and tumor-
igenesis. Proc. Natl. Acad. Sci. U. S. A. 107 (51), 22237–22242.
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D.R., Wieland, S.F.,
Uprichard, S.L., Wakita, T., Chisari, F.V., 2005. Robust hepatitis C virus infection
in vitro. Proc. Natl. Acad. Sci. U. S. A. 102 (26), 9294–9299.
